According to Instarem’s global head, Yogesh Sangle, “While corporate income tax rebates are a welcome measure for profitable ...

Intra-ImmuSG seeks to develop a safer and more effective cancer therapy via a combination of a targeted therapy and immunotherapy.

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares closed lower on Monday potentially following the company's announcement of Dan Kirby as Chief Commercial Officer.

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

The Chinese Communist Party, essentially a criminal organization, invests an entire supply chain into shipping opioid ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

The year started strong for huge rounds, as the first month saw a trio of billion-dollar raises and a slew of others of more ...

We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at ...

China on Tuesday slapped tariffs on US imports in a rapid response to new US duties on Chinese goods, renewing a trade war between the world’s top two economies as President Donald Trump sought to ...

China imposed tariffs on some US imports on Tuesday, the 4th of February, in a swift response to new US tariffs on Chinese ...

Conservation science has entered a new era, thanks to advancements in biotechnology. As habitats shrink and species face ...

Understanding the different types of immune dysregulation that cause sepsis will enable targeted treatments, lower future death tolls, and prevent lingering illness like long COVID-19.